Home

UPLIFT® - Co-Primary Endpoints

Yearly rate of decline of FEV (trough and
peak) over time in patients with COPD, from day
30 until the completion of double-blind treatment.


References can be found here

















PfizerBoehringer Ingelheim
SitemapTerms of UseImprintPfizerBoehringer Ingelheim